1. Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol. 2010; 162:1009–1020.
Article
2. Tóth M, Grossman A. Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome. Clin Endocrinol (Oxf). 2013; 79:1–11.
Article
3. Mancini T, Doga M, Mazziotti G, et al. Cushing's syndrome and bone. Pituitary. 2004; 7:249–252.
Article
4. Kawamata A, Iihara M, Okamoto T, et al. Bone mineral density before and after surgical cure of Cushing's syndrome due to adrenocortical adenoma: prospective study. World J Surg. 2008; 32:890–896.
Article
5. van der Eerden AW, den Heijer M, Oyen WJ, et al. Cushing's syndrome and bone mineral density: lowest Z scores in young patients. Neth J Med. 2007; 65:137–141.
6. Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003; 88:5593–5602.
Article
7. Han JY, Lee J, Kim GE, et al. A case of cushing syndrome diagnosed by recurrent pathologic fractures in a young woman. J Bone Metab. 2012; 19:153–158.
Article
8. Jung MH, Choi H, Kim JY, et al. Vertebral compression fracture in Cushing's syndrome with adrenal adenoma. J Korean Soc Osteoporos. 2009; 7:209–213.
9. Longo DL, Fauci AS, Kasper DL, et al. Harrison's principles of internal medicine. 18th ed. New York, NY: McGraw-Hill;2012.
10. Boscaro M, Barzon L, Fallo F, et al. Cushing's syndrome. Lancet. 2001; 357:783–791.
Article
11. Vestergaard P, Lindholm J, Jørgensen JO, et al. Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol. 2002; 146:51–56.
Article
12. Camozzi V, Sanguin F, Albigier N, et al. Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome. Eur J Endocrinol. 2010; 162:85–90.
Article
13. Minetto M, Reimondo G, Osella G, et al. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Osteoporos Int. 2004; 15:855–861.
Article
14. Ohmori N, Nomura K, Ohmori K, et al. Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome. Endocr J. 2003; 50:1–7.
Article
15. Mazziotti G, Angeli A, Bilezikian JP, et al. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab. 2006; 17:144–149.
Article
16. Canalis E. Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab. 1996; 81:3441–3447.
Article
17. Manning PJ, Evans MC, Reid IR. Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf). 1992; 36:229–234.
Article
18. Kristo C, Jemtland R, Ueland T, et al. Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study. Eur J Endocrinol. 2006; 154:109–118.
Article
19. Luisetto G, Zangari M, Camozzi V, et al. Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome. Osteoporos Int. 2001; 12:956–960.
Article
20. Di Somma C, Pivonello R, Loche S, et al. Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study. Clin Endocrinol (Oxf). 2003; 58:302–308.
Article